From: Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis
CHARACTERISTICS | WITHOUT RECURRENCE N(%) | WITH RECURRENCE N(%) |
---|---|---|
Age (years) | ||
<57 | 14 (48.2) | 29 (64.4) |
>57 | 15 (51.8) | 16 (35.6) |
Menopausal status | ||
Premenopausal | 11 (37.9) | 11 (24.4) |
Postmenopausal | 18 (62.1) | 34 (75.6) |
Tumoral size | ||
T1 | 14 (48.2) | 15 (33.3) |
T2 | 15 (51.8) | 30 (66.7) |
Nodal status | ||
N- | 14 (48.2) | 22 (48.8) |
N+ | 15 (51.8) | 23 (51.2) |
Histological grade | ||
Well dif | 11 (37.9) | 10 (22.2) |
Mod dif | 15 (51.7) | 20 (44.4) |
Poorly dif | 3 (10.4) | 15 (33.4) |
Nottingham pronostic index | ||
<3.4 | 10 (34.4) | 12 (26.7) |
3.4-5.4 | 16(55.1) | 21 (46.6) |
>5.4 | 3 (10.5) | 12 (26.7) |
Estrogen receptors | ||
Negative | 10 (34.4) | 28 (62.8) |
Positive | 19 (65.6) | 17 (37.8) |
Progesterone receptors | ||
Negative | 11 (37.9) | 32 (71,1) |
Positive | 18 (62.1) | 13 (28,9) |
Desmoplasia | ||
Negative | 11 (37.9) | 11 (24.4) |
Positive | 18 (62.1) | 34 (75.5) |
Peritumoral inflammation | ||
No | 15 (51.7) | 20 (44.4) |
Mild | 13 (44.8) | 24 (53.3) |
Intense | 1 (3.5) | 1 (2.3) |
Tumor progress | ||
Expansive | 16 (55.1) | 17 (37.7) |
Infiltrating | 13 (44.9) | 28 (62.3) |
Mitosis | ||
<10 | 16 (55.1) | 18 (40) |
>10 | 13 (44.9) | 27 (60) |
Tumoral necrosis | ||
No | 26 (89.6) | 37 (82.2) |
Focal | 2 (6.9) | 7 (15.5) |
Extense | 1 (3.5) | 1 (2.3) |